ARF1 — ADP Ribosylation Factor 1
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ARF1</th></tr>
<tr><td><strong>Protein Name</strong></td><td>ADP Ribosylation Factor 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[ARF1](/genes/arf1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P84077](https://www.uniprot.org/uniprot/P84077)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Arf family, GTP-binding proteins</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>20.7 kDa</td></tr>
<tr><td><strong>GTP/GDP Binding</strong></td><td>GTP-bound = active, GDP-bound = inactive</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Golgi apparatus, plasma membrane, endosomes</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/obesity" style="color:#ef9a9a">Obesity</a>, <a href="/wiki/stroke" style="color:#ef9a9a">Stroke</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">31 edges</a></td>
</tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
ARF1 (ADP Ribosylation Factor 1) is a small GTPase belonging to the ARF family of regulatory proteins. Originally identified as a cofactor for cholera toxin ADP-ribosylation, ARF1 is now recognized as a master regulator of membrane trafficking in eukaryotic cells. ARF1 controls vesicle formation, cargo transport, and organelle integrity through its GTPase cycle. Recent research has implicated ARF1 dysfunction in neurodegenerative diseases, particularly those involving protein aggregation like [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) [1].
Structure and GTPase Cycle
Protein Architecture
ARF1 is a 181-amino acid protein with the classic GTPase fold:
- N-terminal amphipathic helix: Myristoylated, anchors to membranes
- Switch I region: Conformational change between GTP/GDP states
- Switch II region: Critical for GTP hydrolysis
- GTP-binding domains: N, K, and D loops for nucleotide coordination
GTPase Cycle
ARF1 cycles between active (GTP-bound) and inactive (GDP-bound) states:
Activation: GEFs (Arfgef1/BIG1, Arfgef2/BIG2) catalyze GDP→GTP exchange
Membrane recruitment: GTP-ARF1 exposes N-terminal helix, inserts into membrane
Effector binding: Active ARF1 recruits coat proteins, adaptors, and enzymes
Hydrolysis: GAPs (ArfGAP1, ArfGAP2/3) accelerate GTP hydrolysis
Release: GDP-ARF1 dissociates from membrane for recyclingCellular Functions
Golgi Trafficking
ARF1 is essential for Golgi apparatus function:
- COPI vesicle formation: Recruits coatomer complex to Golgi membranes
- Cargo sorting: Selects proteins and lipids for transport
- Golgi maintenance: Essential for Golgi stack organization
- ER-Golgi transport: Regulates anterograde and retrograde trafficking
Endocytic Pathways
ARF1 also regulates endosomal trafficking:
- Endosome function: Modulates endosomal maturation
- Lysosomal targeting: Directs cargo for degradation
- Recycling: Facilitates receptor recycling
ARF1 influences lipid homeostasis:
- Phospholipase D activation: PLD generates phosphatidic acid
- Phosphatidylinositol metabolism: Regulates PI4P levels at Golgi
- Membrane curvature: Facilitates vesicle budding
ARF1 in Neurodegeneration
Alzheimer's Disease
ARF1 dysfunction may contribute to [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms:
Amyloid Processing
The secretase enzymes that process [amyloid precursor protein](/proteins/app) are localized to Golgi and endosomes:
- ARF1 regulates [APP](/entities/app-protein) trafficking through the secretory pathway
- Altered ARF1 function may increase amyloidogenic processing
- Golgi fragmentation in AD [neurons](/entities/neurons) may involve ARF1 dysregulation
Tau Pathology
ARF1 interacts with [tau](/proteins/tau) phosphorylation pathways:
- GSK3β, a key tau kinase, may be regulated by ARF1
- Vesicular trafficking deficits affect tau spreading
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), ARF1 plays roles in:
Alpha-synuclein trafficking: ARF1 regulates intracellular [alpha-synuclein](/proteins/alpha-synuclein) localization
[Autophagy](/entities/autophagy): ARF1 modulates autophagosome formation
Lysosomal function: Key for protein clearance pathways
Mitochondrial dynamics: Links to PD-relevant pathwaysAmyotrophic Lateral Sclerosis (ALS)
ARF1 dysfunction may contribute to ALS pathogenesis:
- Vesicle transport deficits in motor neurons
- Protein aggregate clearance issues
- ER-Golgi stress responses
ARF1 and Membrane Traffic in Neurodegeneration
Protein Aggregation
Impaired vesicular trafficking contributes to protein aggregation:
- Secretory pathway stress: Accumulation of misfolded proteins
- Autophagy-lysosome pathway: Defects in aggregate clearance
- Axonal transport: Disrupted vesicle trafficking in neurons
Membrane Lipid Alterations
Changes in membrane composition affect ARF1 function:
- Altered phosphoinositide metabolism
- Cholesterol accumulation
- Membrane fluidity changes
Therapeutic Implications
Targeting ARF1 Pathways
ARF1 and its regulators represent therapeutic targets:
ARF GEFs: BIG1/BIG2 inhibitors for certain conditions
ARF GAPs: Modulators of ARF activity
Effector interactions: Disrupt toxic protein-protein interactionsDelivery Mechanisms
For neurodegenerative applications:
- Small molecule modulators of ARF1 cycle
- Peptide inhibitors of specific interactions
- Gene therapy approaches
Summary
ARF1 is a small GTPase that regulates essential membrane trafficking pathways in all eukaryotic cells. In neurons, ARF1 controls vesicular transport critical for synaptic function, protein homeostasis, and organelle maintenance. Dysregulation of ARF1 function contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders through effects on protein processing, trafficking, and aggregation. Understanding ARF1 biology may reveal therapeutic strategies for these conditions.
See Also
- [ Protein](/proteins/app)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [Parkinson's disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Unknown, D'Souza-Schorey & Chavrier, ARF GTPases in membrane trafficking (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16493416/)
[Unknown, Gillingham & Munro, The ARF family (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17961138/)
[Zhang et al., ARF1 and Alzheimer's disease (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29550620/)Pathway Diagram
The following diagram shows the key molecular relationships involving ARF1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Expression Profile
Sources: [GTEx Portal v10](https://gtexportal.org/home/gene/arf1) | [Allen Brain Atlas](https://www.brain-map.org/)
| Rank | Tissue | Median TPM |
|------|--------|------------|
| 1 | Artery Aorta | 423.29 |
| 2 | Cells Cultured fibroblasts | 420.30 |
| 3 | Artery Tibial | 391.48 |
| 4 | Lung | 380.36 |
| 5 | Uterus | 371.89 |
| 6 | Cervix Endocervix | 366.12 |
| 7 | Fallopian Tube | 357.18 |
| 8 | Pituitary | 355.63 |
| 9 | Artery Coronary | 354.98 |
| 10 | Thyroid | 331.36 |
| 11 | Cervix Ectocervix | 322.72 |
| 12 | Ovary | 315.52 |
| 13 | Testis | 294.05 |
| 14 | Cells EBV-transformed lymphocytes | 293.92 |
| 15 | Nerve Tibial | 292.61 |
Highest expression outside brain: Artery Aorta (423.29 TPM)